Real-time enrollment status for this depression, postpartum clinical trial
Current Status
Recruiting
Checked: September 17, 2026 at 2:46 AM UTC
| NCT Number | NCT07822321 |
| Recruiting Status | Recruiting |
| Condition | Depression, Postpartum |
| Phase | PHASE3 |
| Target Enrollment | 120 participants |
| Active Locations | 16 sites in the US |
| Sponsor | Lipocine Inc. |
| Last Updated on CT.gov | September 16, 2026 (Yesterday) |
As of September 17, 2026: Clinical trial NCT07822321 is currently recruiting participants. This phase3 study for depression, postpartum is actively seeking new participants at 16 locations across the United States. The study is sponsored by Lipocine Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07822321 is actively recruiting participants as of September 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 16 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07822321 was last updated Yesterday (September 16, 2026). HelloStudys verifies this status automatically.